-
NSE
2,043.00 1,640.25(%) -
Happy Forgings
1,845.00 991.20(%) -
Lenskart Solut.
752.85 767.40(%) -
Cummins India
4,043.00 3,883.30(%) -
Urban Company
160.40 96.35(%) -
SBI
1,114.00 1,234.80(%) -
Power Grid Corpn
256.95 242.30(%) -
Reliance Industries
1,374.00 1,611.20(%) -
Angel One
379.00 379.00(%) -
Bharat Forge
1,707.00 1,328.15(%) -
N S D L
819.65 1,165.75(%) -
Kaynes Tech
2,851.00 2,780.00(%) -
Persistent Systems
5,902.05 4,242.65(%) -
M & M
3,435.90 3,840.00(%) -
Apar Inds.
14,085.00 6,800.00(%) -
Hyundai Motor I
2,151.00 2,461.55(%) -
Tata Motors
448.50 508.95(%) -
Ashok Leyland
160.65 138.05(%) -
Vardhman Textile
538.55 687.70(%) -
Jio Platforms
1,391.70 1,356.40(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Gujarat Themis Biosyn Ltd Pharmaceuticals - Indian - Bulk Drugs
- Themis
- BSE Code : 216.0
- ISIN : INE942C01045
-
Today’s Low
345.00 -
Today’s High
365.00
-
Open
359.25 -
Perv Close
359.25 -
52W Low
225.05 -
52W High
470.05
Key Indicators
-
P/E(TTM)
105.70
-
Mar.Cap (₹Cr.)
4,542.29
-
Div & Yield %
0.16
-
Book Value(₹)
81.08
-
Debt-Equity Ratio
-2.85
-
AGM Date
17-Nov-2026
-
EPS
3.30
-
P/E Ratio
105.70
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
4,542.29
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
13.02
-
BV (₹)
81.10
-
Sales( ₹ in Cr.)
165.82
-
NP (in Cr.)
46.68
-
NP Var(%)
-4.0
-
Div%
67.0
-
CPS (₹)
4.60
-
EPS (₹)
3.60
-
Traded Value (₹ in Lakhs)
4,681.56
-
52 Week High
470.05
-
52 Week Low
225.05
-
Price BSE
360.0
-
Price NSE
359.00
-
Market Capital( in Cr.)
4,681.56
-
P/C Ratio
78.60
-
P/E Ratio
100.40
-
Price Vs.BV
3.60
-
27-Oct-2026( 01:10)
Corporate News - Gujar... - <p>Gujarat Themis Biosyn Limit...
-
12-Oct-2026( 07:29)
Corporate News - Gujar... - <p>Gujarat Themis Biosyn Limit...
-
30-Sep-2026( 07:36)
Corporate News - Gujar... - <p>Gujarat Themis Biosyn Limit...
-
23-Sep-2026( 06:58)
Corporate News - Gujar... - <p>Gujarat Themis Biosyn Limit...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 165.82 | 150.80 | 169.82 | 148.39 | 114.85 | 90.56 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 165.82 | 150.80 | 169.82 | 148.39 | 114.85 | 90.56 |
| Other Income | 2.43 | 2.44 | 4.38 | 6.59 | 4.05 | 3.27 |
| Stock Adjustments | 9.03 | 1.27 | -11.01 | 3.24 | 5.13 | 0.38 |
| Total Income | 177.28 | 154.51 | 163.19 | 158.22 | 124.03 | 94.21 |
| EXPENDITURE : | ||||||
| Raw Materials | 30.43 | 25.78 | 25.67 | 29.73 | 21.75 | 15.75 |
| Power and Fuel Cost | 31.89 | 26.63 | 26.53 | 26.41 | 21.73 | 16.57 |
| Employee Cost | 14.99 | 11.44 | 10.21 | 7.75 | 7.08 | 7.11 |
| Other Manufacturing Expenses | 7.75 | 9.20 | 6.79 | 6.80 | 7.91 | 8.79 |
| Selling and Administration Expenses | 8.37 | 5.81 | 8.59 | 6.66 | 2.31 | 1.86 |
| Miscellaneous Expenses | 5.01 | 4.36 | 2.29 | 0.64 | 1.15 | 0.53 |
| Employee Benefit Expenses | 14.99 | 11.44 | 10.21 | 7.75 | 7.08 | 7.11 |
| Less: Preoperative Expenditure | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 98.43 | 83.24 | 80.09 | 77.99 | 61.94 | 50.61 |
| Operating Profit | 78.85 | 71.27 | 83.10 | 80.22 | 62.10 | 43.59 |
| Interest | 3.84 | 0.36 | 0.23 | 0.18 | 0.83 | 0.98 |
| Gross Profit | 75.01 | 70.91 | 82.87 | 80.04 | 61.27 | 42.61 |
| Depreciation | 12.92 | 5.37 | 3.54 | 2.58 | 2.23 | 1.73 |
| Profit Before Tax | 62.09 | 65.54 | 79.33 | 77.46 | 59.04 | 40.88 |
| Current Tax | 10.79 | 16.49 | 19.80 | 19.24 | 15.34 | 10.58 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 4.62 | 0.28 | 0.38 | 0.26 | 0.07 | 0.13 |
| Reported Net Profit | 46.68 | 48.77 | 59.16 | 57.97 | 43.62 | 30.18 |
| Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Adjusted Net Profit | 46.68 | 48.77 | 59.16 | 57.97 | 43.62 | 30.17 |
| Adjustment below Net Profit | 0.01 | -1.42 | -0.03 | 0.06 | -0.08 | -0.03 |
| P & L Balance brought forward | 237.33 | 191.79 | 139.56 | 93.74 | 60.36 | 32.61 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 7.30 | 1.82 | 6.90 | 12.20 | 10.17 | 2.40 |
| P & L Balance carried down | 276.71 | 237.33 | 191.79 | 139.56 | 93.74 | 60.36 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 67.00 | 67.00 | 100.00 | 108.00 | 220.00 | 0.00 |
| Dividend Per Share(Rs) | 0.67 | 0.67 | 1.00 | 5.40 | 11.00 | 0.00 |
| Earnings Per Share-Unit Curr | 4.28 | 4.48 | 8.14 | 39.90 | 30.03 | 20.77 |
| Earnings Per Share(Adj)-Unit Curr | 4.28 | 4.48 | 5.43 | 5.32 | 4.00 | 2.77 |
| Book Value | 26.41 | 22.79 | 27.72 | 102.66 | 71.11 | 48.14 |
| Book Value(Adj)-Unit Curr | 26.41 | 22.79 | 18.48 | 13.69 | 9.48 | 6.42 |
